Concepedia

Gisela Claassen

GC

Statistics

Publications

12

Citations

1.1K

H-Index

12

Active since

1998

Affiliations

Vanderbilt University(Current)

Biogen (United States)

Novartis (Switzerland)

Gisela Claassen is an author at Vanderbilt University specializing in life sciences, oncology, and drug discovery.

Publications per year

1998–2012

12

Publications

12

A role for transcriptional repression of p21 <sup>CIP1</sup> by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest

Gisela Claassen · Proceedings of the National Academy of Sciences · 2000 · 258 citations

, , +17

The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals

David Chang, Gisela Claassen, Michael D. Cole · Molecular and Cellular Biology · 2000 · 133 citations

, , +17

Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen

John D. Hooper, Andries Zijlstra, Ronald T. Aimes et al. · Oncogene · 2003 · 130 citations

, , +10

Nuclear Hormone Receptor NR4A2 Is Involved in Cell Transformation and Apoptosis

Ke Ning, Gisela Claassen, Dehua Yu et al. · Cancer Research · 2004 · 128 citations

, , +17

Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis

Qiurong Xiao, Gisela Claassen, Jingyu Shi et al. · Genes & Development · 1998 · 119 citations · Full text

, , +17

1–5 of 12